The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
Open accessAbstract
Objectives: This is the first of a pair of studies designed to assess efficacy, safety and tolerability of onabotulinumtoxinA (BOTOX®) as headache prophylaxis in adults with chronic migraine. Methods: The Phase III REsearch Evaluating Migraine Prophylaxis Therapy 1 (PREEMPT 1) is a phase 3 study, with a 24-week, double-blind, parallel-group, placebo-controlled phase followed by a 32-week, open-label phase. Subjects were randomized (1:1) to injections every 12 weeks of onabotulinumtoxinA (155 U–195 U; n = 341) or placebo ( n = 338) (two cycles). The primary endpoint was mean change from baseline in headache episode frequency at week 24. Results: No significant between-group difference for onabotulinumtoxinA versus placebo was observed for the primary endpoint, headache episodes (−5.2 vs. −5.3; p = 0.344). Large within-group decreases from baseline were observed for all efficacy variables. Significant between-group differences for onabotulinumtoxinA were observed for the secondary endpoints, headache days ( p = .006) and migraine days ( p = 0.002). OnabotulinumtoxinA was safe and well tolerated, with few treatment-related adverse events. Few subjects discontinued due to adverse events. Conclusions: There was no between-group difference for the primary endpoint, headache episodes. However, significant reductions from baseline were observed for onabotulinumtoxinA for headache and migraine days, cumulative hours of headache on headache days and frequency of moderate/severe headache days, which in turn reduced the burden of illness in adults with disabling chronic migraine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The International Classification of Headache Disorders
Olesen, J. (2008) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2008.01121.x · Cited by 2,321
A six-item short-form survey for measuring headache impact: The HIT-6™
Kosinski, M., Bayliss, M. S., Bjorner, J. B., Ware, J. E., Garber, W. H., Batenhorst, A., Cady, R., Dahlöf, C. G. H., Dowson, A., & Tepper, S. (2003) · Quality of Life Research · doi:10.1023/a:1026119331193 · Cited by 1,376 · cited 1×
“Other a priori defined analyses included three assessments of disability and HRQoL measured by the mean change from baseline at week 24 in total Headache Impact Test (HIT)-6 score (33), the Migraine Specific Quality of Life Questionnaire [MSQ v.”
MethodDiener, H., Dodick, D., Aurora, S., Turkel, C., DeGryse, R., Lipton, R., Silberstein, S., & Brin, M. (2010) · Cephalalgia · doi:10.1177/0333102410364677 · Cited by 960
Self-citationNew Appendix Criteria Open for a Broader Concept of Chronic Migraine
Olesen, J., Bousser, M.-G., Diener, H.-C., Dodick, D., First, M., Goadsby, P., Göbel, H., Lainez, M., Lance, J., Lipton, R., et al. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2006.01172.x · Cited by 909
Self-citationEpidemiology of Chronic Daily Headache in the General Population
Castillo, J., Muñoz, P., Guitera, V., & Pascual, J. (1999) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1999.3903190.x · Cited by 714
Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
Buse, D. C., Manack, A., Serrano, D., Turkel, C., & Lipton, R. B. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.192492 · Cited by 622
Self-citationPrevalence of Frequent Headache in a Population Sample
Scher, A. I., Stewart, W. F., Liberman, J., & Lipton, R. B. (1998) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1998.3807497.x · Cited by 606
Self-citationDiener, H.-C., Bussone, G., Oene, J. V., Lahaye, M., Schwalen, S., & Goadsby, P. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01326.x · Cited by 561
Self-citationInternational Classification of Headache Disorders
Olesen, J. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30085-1 · Cited by 544
Silberstein, S. D., Lipton, R. B., Dodick, D. W., Freitag, F. G., Ramadan, N., Mathew, N., Brandes, J. L., Bigal, M., Saper, J., Ascher, S., et al. (2007) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00684.x · Cited by 497
Self-citationChronic migraine in the population: Burden, diagnosis, and satisfaction with treatment
Bigal, M. E., Serrano, D., Reed, M., & Lipton, R. B. (2008) · Neurology · doi:10.1212/01.wnl.0000323925.29520.e7 · Cited by 490
Self-citationBotulinum toxin type a induces direct analgesic effects in chronic neuropathic pain
Ranoux, D., Attal, N., Morain, F., & Bouhassira, D. (2008) · Annals of Neurology · doi:10.1002/ana.21427 · Cited by 459
Medication-overuse headache: a worldwide problem
Diener, H.-C., & Limmroth, V. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00824-5 · Cited by 455
Self-citationLocalized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
Brin, M. F., Fahn, S., Moskowitz, C., Friedman, A., Shale, H. M., Greene, P. E., Blitzer, A., List, T., Lange, D., Lovelace, R. E., et al. (1987) · Movement Disorders · doi:10.1002/mds.870020402 · Cited by 417
Self-citationBotulinum toxin in the treatment of myofascial pain syndrome
Cheshire, W. P., Abashian, S. W., & Mann, D. J. (1994) · Pain · doi:10.1016/0304-3959(94)90048-5 · Cited by 340
Guidelines for Controlled Trials of Prophylactic Treatment of Chronic Migraine in Adults
Silberstein, S., Tfelt-Hansen, P., Dodick, D., Limmroth, V, Lipton, R., Pascual, J., Wang, S., & for the Task Force of the International Headache Society Clinical Trials Subcommittee (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01555.x · Cited by 303
Self-citationBotulinum toxin A and chronic low back pain: A randomized, double-blind study
Foster, L., Clapp, L., Erickson, M., & Jabbari, B. (2001) · Neurology · doi:10.1212/wnl.56.10.1290 · Cited by 297
Mathew, N. T., Frishberg, B. M., Gawel, M., Dimitrova, R., Gibson, J., Turkel, C., & BOTOX CDH Study Group (2005) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2005.05066.x · Cited by 266
Self-citationDevelopment and Validation of the Migraine‐Specific Quality of Life Questionnaire
Jhingran, P., Osterhaus, J. T., Miller, D. W., Lee, J. T., & Kirchdoerfer, L. (1998) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1998.3804295.x · Cited by 252
Double‐Blind Trial of Fluoxetine: Chronic Daily Headache and Migraine
Saper, J. R., Silberstein, S. D., Lake, A. E., & Winters, M. E. (1994) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1994.hed3409497.x · Cited by 234
Self-citationDodick, D. W., Mauskop, A., Elkind, A. H., DeGryse, R., Brin, M. F., Silberstein, S. D., & BOTOX CDH Study Group (2005) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2005.05068.x · Cited by 221
Self-citationAurora, S. K., Barrodale, P. M., Tipton, R. L., & Khodavirdi, A. (2007) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2007.00853.x · Cited by 220
Self-citationPrevalence and description of chronic daily headache in the general population in France
Lantéri-Minet, M., Auray, J.-P., El Hasnaoui, A., Dartigues, J.-F., Duru, G., Henry, P., Lucas, C., Pradalier, A., Chazot, G., & Gaudin, A.-F. (2003) · Pain · doi:10.1016/s0304-3959(02)00348-2 · Cited by 213
Dodick, D. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp042897 · Cited by 191
Self-citationManagement of Spasticity Associated Pain with Botulinum Toxin A
Wissel, J., Müller, J., Dressnandt, J., Heinen, F., Naumann, M., Topka, H., & Poewe, W. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(00)00146-9 · Cited by 185
Silberstein, S. D., Stark, S. R., Lucas, S. M., Christie, S. N., Degryse, R. E., & Turkel, C. C. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.9.1126 · Cited by 176
Self-citationSilberstein, S., Göbel, H., Jensen, R., Elkind, A., DeGryse, R., Walcott, J., & Turkel, C. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2006.01114.x · Cited by 174
Self-citationSafety and efficacy of botulinum toxin type A following long‐term use
Naumann, M., Albanese, A., Heinen, F., Molenaers, G., & Relja, M. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01652.x · Cited by 169
Topiramate in the Treatment of Chronic Migraine
Silvestrini, M., Bartolini, M., Coccia, M., Baruffaldi, R., Taffi, R., & Provinciali, L. (2003) · Cephalalgia · doi:10.1046/j.1468-2982.2003.00592.x · Cited by 162
Coeytaux, R. R., Kaufman, J. S., Chao, R. A., Mann, J. D., & DeVellis, R. F. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.05.010 · Cited by 161
Aurora, S. K., Gawel, M. J., Brandes, J. L., Pokta, S., VanDenburgh, A. M., & for the BOTOX North American Episodic Migraine Study Group (2006) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00624.x · Cited by 156
Self-citationSaper, J. R., Lake, A. E., Cantrell, D. T. C., Winner, P. K., & White, J. (2002) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2002.02122.x · Cited by 142
Primary chronic daily headache and its subtypes in adolescents and adults
BIGAL, M. E., Lipton, R. B., Tepper, S. J., Rapoport, A. M., & Sheftell, F. (2004) · Neurology · doi:10.1212/01.wnl.0000137039.08724.18 · Cited by 140
Self-citationRelja, M., Poole, A., Schoenen, J., Pascual, J., Lei, X., & Thompson, C. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01315.x · Cited by 132
The Importance of Placebo in Headache Research
Diener, H., Schorn, C. F., Bingel, U., & Dodick, D. (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01660.x · Cited by 117
Self-citationCole, J. C., Lin, P. L., & Rupnow, M. F. T. (2007) · Quality of Life Research · doi:10.1007/s11136-007-9217-1 · Cited by 107
Field Testing Alternative Criteria for Chronic Migraine
Bigal, M., Tepper, S. J., Sheftell, F., Rapoport, A. M., & Lipton, R. B. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2006.01128.x · Cited by 58
Self-citationLipton, R. B., & BIGAL, M. E. (2003) · Neurology · doi:10.1212/wnl.61.2.154 · Cited by 54
Self-citationBotulinum toxin type A for the treatment of migraine
Aurora, S. K. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.8.1085 · Cited by 35
Self-citation
Cited by
Dodick, D. W., Turkel, C. C., DeGryse, R. E., Aurora, S. K., Silberstein, S. D., Lipton, R. B., Diener, H., & Brin, M. F. (2010) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01678.x · Cited by 994
Self-citationDiener, H., Dodick, D., Aurora, S., Turkel, C., DeGryse, R., Lipton, R., Silberstein, S., & Brin, M. (2010) · Cephalalgia · doi:10.1177/0333102410364677 · Cited by 960
Self-citationFremanezumab for the Preventive Treatment of Chronic Migraine
Silberstein, S. D., Dodick, D. W., Bigal, M. E., Yeung, P. P., Goadsby, P. J., Blankenbiller, T., Grozinski-Wolff, M., Yang, R., Ma, Y., & Aycardi, E. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709038 · Cited by 792
Self-citationAilani, J., Burch, R. C., Robbins, M. S., & the Board of Directors of the American Headache Society (2021) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.14153 · Cited by 766
Tepper, S., Ashina, M., Reuter, U., Brandes, J. L., Doležil, D., Silberstein, S., Winner, P., Leonardi, D., Mikol, D., & Lenz, R. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30083-2 · Cited by 722
Self-citation
Metadata
- Authors
- Aurora, S., Dodick, D., Turkel, C., DeGryse, R., Silberstein, S., Lipton, R., Diener, H., & Brin, M.
- Venue
- Cephalalgia
- Publisher
- SAGE Publications
- Published
- 2010-03-17
- Volume
- 30
- Issue
- 7
- Pages
- 793-803
- ISSN
- 0333-1024 (ISSN-L)
- 1468-2982
- OpenAlex
- W2007410119
- Cited by
- 1,047
- References
- 39
- FWCI
- 37.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.